This journal is
indexed in Scopus

Year 2019 Vol. 27 No 3


DOI:   |  



National Pirogov Memorial Medical University 1, Vinnitsa,
Ukrainian Medical Stomatological Academy 2, Poltava,

According to the literature data, microbiota of complications in surgical hospitals consists mainly of representatives of Staphylococcus spp., Enterococcus spp., Escherichia spp., Enterobacter spp., Klebsiella spp., and Pseudomonas spp. However, the spectrum of microorganisms differs depending on the location of the lesions, therapy tactics and the type of unit, where a patient is treated. Nowadays the rapid acquisition of resistance to chemotherapeutic agents by pathogens is becoming the most ambitious problem of modern medicine. In hospitals and intensive care units, the situation is aggravated by the emergence of multi-resistant hospital strains of microorganisms. The mechanisms of bacterial resistance to antibiotics are diverse and can be carried out both at the genetic and at the biochemical level.
The incidence of infectious and inflammatory postoperative complications and increase of the problem of antibiotic resistance among microorganisms dictate the need for careful monitoring of the epidemic situation in hospitals and studying the changing tendencies in the spectrum of dominant pathogens. Moreover, developing and introducing into the clinic of new antibiotics and drugs with antimicrobial activity, revision of existing algorithms for the treatment and prevention of complications arising on the background of surgical interventions are necessary.

Keywords: anti-bacterial agents, antibiotic-resistance, infectious-inflammatory, nosocomial, postoperative complications, surgical infection
p. 318-327 of the original issue
  1. Report on the burden of endemic health care-associated infection worldwide. A systematic review of the literature [Internet]. Geneva, Switzerland: WHO; 2011 [cited 2018 Aug 30]. Available from:;jsessionid=97CC5B3B75D48F65A3F0C8FEE5B1DF86?sequence=1
  2. Global Guidelines for the Prevention of Surgical Site Infection [Internet]. Geneva, Switzerland: WHO; 2016. San Francisco: Matthew Holt; 2003 Oct [cited 2018 Aug 30]. Available from:;jsessionid=1F8A9546C46F1803027E22A3F82DBEE4?sequence=1
  3. Surveillance of surgical site infections in Europe 20102011 [Internet]. Stockholm: ECDC; 2013 Oct [cited 2018 Aug 30]. Available from:
  4. Allegranzi B, Bischoff P, de Jonge S, Kubilay NZ, Zayed B, Gomes SM, Abbas M, Atema JJ, Gans S, van Rijen M, Boermeester MA, Egger M, Kluytmans J, Pittet D, Solomkin JS. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016 Dec;16(12):e276-e87. doi: 10.1016/S1473-3099(16)30398-X
  5. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003 Aug;54(4):258-66; quiz 321. doi: 10.1016/S0195-6701(03)00150-6
  6. Surveillance of surgical site infections in NHS hospitals in England (Apr 2016 to Mar 2017) [Internet]. London: Public Health England; Dec 2017. 50 p. Available from:
  7. Kramer A, Pochhammer J, Walger P, Seifert U, Ruhnke M, Harnoss JC. Erregerspektrum postoperativer Komplikationen in der Viszeralchirurgie. Der Chirurg. 2017 May;88(Is 5):369-76. doi: 10.1007/s00104-017-0382-7
  8. Briskin BS, Khachatrian NN. Vnutribolnichnye infektsii i ikh profilaktika: vzgliad khirurga. Consilium Medicum. 2002;4(6):309-12. (in Russ.)
  9. Popov DA. Postoperative infectious complications in cardiac surgery. Annaly Khirurgii. 2013;5:15-21. (in Russ.)
  10. Kireev SS, Umarova DI. Fan-associated pneumonia: diagnostics, prevention, treatment (literature report). Vestn Novykh Med Tekhnologii. Elektronnoe izdanie. 2017;2(Publ 8-4). (in Russ.)
  11. Eliseeva EV, Petrova OS, Kirillin DN, Romanchenko EF. Contemporary data abolt etiology and pathogenesis of nosocomial pneumonia. Modern approaches of antibiotic therapy. Tikhookean Med Zhurn. 2005;(1):9-12. (in Russ.)
  12. Katchanov J, Asar L, Klupp EM, Both A, Rothe C, König C, Rohde H, Kluge S, Maurer FP. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations. PLoS One. 2018 Apr 12;13(4):e0195757. doi: 10.1371/journal.pone.0195757. eCollection 2018.
  13. Bouglé A, Bombled C, Margetis D, Lebreton G, Vidal C, Coroir M, Hajage D, Amour J. Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: Epidemiology and risk factors of treatment failure. PLoS One. 2018 Apr 13;13(4):e0194976. doi: 10.1371/journal.pone.0194976. eCollection 2018.
  14. Rello J, Nieto M, Solé-ViolÁn J, Wan Y, Gao X, Solem CT, De Salas-Cansado M, Mesa F, Charbonneau C, Chastre J. Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective. Med Intensiva. 2016 Nov;40(8):474-82. doi: 10.1016/j.medin.2016.01.007
  15. Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):1999-2006. doi: 10.1007/s10096-016-2703-z
  16. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003 May 1;36(9):1103-10. doi: 10.1086/374339
  17. Viderman D, Khamzina Y, Kaligozhin Z, Khudaibergenova M, Zhumadilov A, Crape B, Azizan A. An observational case study of hospital associated infections in a critical care unit in Astana, Kazakhstan. Antimicrob Resist Infect Control. 2018 Apr 25;7:57. doi: 10.1186/s13756-018-0350-0. eCollection 2018.
  18. Calik Basaran N, Ascioglu S. Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature. Ther Adv Infect Dis. 2017 Nov;4(6):171-91. doi: 10.1177/2049936117733394
  19. Korytny A, Riesenberg K, Saidel-Odes L, Schlaeffer F, Borer A. Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance. Infect Dis (Lond). 2016;48(6):428-31. doi: 10.3109/23744235.2015.1129551
  20. Montassier E, Batard E, Gastinne T, Potel G, de La Cochetière MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):841-50. doi: 10.1007/s10096-013-1819-7
  21. Ananieva M, Nazarchuk O, Faustova M, Basarab Ya, Loban G. Pathogenicity Factors of Kocuria kristinae Contributing to the Development of Peri-Implant Mucositis. Mal J Med Health Sci. 2018 Oct;14(3):34-38.
  22. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004 Aug 1;39(3):309-17. doi: 10.1086/421946
  23. Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res. 2012 Dec;136(6):997-1003.
  24. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002 Apr;50(4):243-60. doi: 10.1053/jhin.2001.1151
  25. Magill SS, Shields C, Sears CL, Choti M, Merz WG. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy. J Clin Microbiol. 2006 Feb;44(2):529-35. doi: 10.1128/JCM.44.2.529-535.2006
  26. Skobsky YI, Orlov YuA, Skobskaya OY. Experience of prevention of infections inflammatory complications in childrens neurosurgical units. Ukranskii Neirokhrurgchnii Zhurn. 2000;3:70-3. (in Russ.)
  27. Novikov DK, Novikov PD. Klinicheskaia immunologiia. Vitebsk, RB: VGMU; 2006. 392 s. (in Russ.)
  28. Subbotovskaia AI, Kozyreva VS, Kniazkova LG, Lomivorotov VV, Efremov SM, Sergeevichev DS, Subbotovskii AP. Subpopuliatsionnyi sostav limfotsitov posle kardiokhirurgicheskikh vmeshatelstv v usloviiakh iskusstvennogo krovoobrashcheniia. Patologiia Krovoobrashcheniia i Kardiokhirurgiia. 2011;(3);47-50. (in Russ.)
  29. Vaskovskaya OV, Asabaeva RI, Digay LK, Shanazarov NA, Kokoshko AI. Complications after gynecological cancer expanded operations. Nauch Obozrenie. Med Nauki. 2014;(1):58-9. (in Russ.)
  30. Povsic MK, Beovic B, Ihan A. Perioperative Increase in Neutrophil CD64 Expression is an indicator for intra-abdominal infection after colorectal cancer surgery. Radiol Oncol. 2017;51(2):211-20. doi: 10.1515/raon-2016-0016
  31. Faustova MO, Ananieva MM, Basarab YO, Loban GA. Neutrophil bactericidal activity through the stages of placement of different dental implants depending on their chemical composition. Wiad Lek. 2017;70(5):921-24.
  32. Vu Vyet Kuong, Avetikov DS, Shlyikova , Izmaylova V, Kaydashev IP. Incidence of odontogenic phlegmon, ssociated with polymorph variant 896/g of gene TLR4, but not 2258g/a of gene TLR2 but not 2258G/A of gene TLR2. Klnchna Khrurgia. 2014;10:54-56. (in Russ.)
  33. Petrushanko TA, Chereda VV, Loban GA.The relationship between colonization resistance of the oral cavity and individual -typological characteristics of personality: dental aspects [abstract]. Wiad Lek. 2017;70(4):754-57. URL:
  34. Petrushanko TA, Chereda VV, Loban GA. Role of oral cavity colonization resistance in dental caries development. Stomatologiia. 2013;92(1):43-45. Russ.)
  35. Shlyapnikov ME, Belokonev VI, Solovova LD, Merkulova VI, Arutyunyan KN, Ibrahim SA, Danilova NN, Trefilova NN, Karpushina EJ. Tuboovarial abscesses: modern clinial-anatomical and microbiological features, volume of the surgical care, possibility of prediction and correction postoperative complications. Prakt Meditsina. 2010;(4):90-94. (in Russ.)
  36. Svzhak VK, Deineka SЄ. Antibotikorezistentnst: bagatogrannst problemi. Klinichna ta Eksperimentalna Patologiia. 2010;13(2):222-4. (in Ukr.)
  37. Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P, van Ostrum E, Johansen TB. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol. 2014 Jun;32(3):791-801. doi: 10.1007/s00345-013-1154-8
  38. Global action plan on antimicrobial resistance [Internet]. Geneva, Switzerland: WHO; 2015 [cited 2018 Sept 3]. Available from:
  39. Bondar MV, Pilipenko MM, Svntukovskii MIu, Kharchenko LA, Previsla OM, Tsvik M. Antibotikorezistentnst mkroorganzmv: mekhanzmi rozvitku i shliakhi zapobgannia. Meditsina Neotlozh Sostoianii. 2016;(3):11-17. ( in Russ.)
  40. Dubovyk O, Mishyna , Malanchuk S, Kuzmenko A, Kozlov O. Definition of etiological antibiotic sensitivity factors in purulent-inflammatory processes. Georgian Med News. 2017 Oct;(10):133-37.
  41. Xia J, Gao J, Tang W. Nosocomial infection and its molecular mechanisms of antibiotic resistance. Biosci Trends. 2016 Feb;10(1):14-21. doi: 10.5582/bst.2016.01020
  42. Supotnitskiy MV. Mechanisms of Antibiotic Resistance in Bacteria. Biopreparaty. 2011;(2):4-11. (in Russ.)
  43. Tsarev VN, red. Mikrobiologiia, virusologiia i immunologiia polosti rta. Moskva, RF: GEOTAR-Media; 2016. 576 s. Russ.)
  44. Volosovets AP, Krivopustov SP, Iulish EI. Sovremennye vzgliady na problemu antibiotikorezistentnosti i ee preodolenie v klinicheskoi pediatrii. Zdorove Rebenka. 2007;6(9). (in Russ.)
  45. Reshedko GK. Mekhanizmy rezistentnosti k aminoglikozidam u nozokomialnykh gramotritsatelnykh bakterii v Rossii: rezultaty mnogotsentrovogo issledovaniia [Elektronnyi resurs]. (in Russ.)
  46. Singur OA, Singur LG, Lobova TG. Monitoring antibiotikorezistentnosti shtammov S. aureus v mikrobnykh assotsiatsiiakh pri urogenitalnykh infektsiiakh [Elektronnyi resurs]. Evraziiskoe Nauchnoe Obedinenie. 4 s. (in Russ.)
  47. Gumaneneko EK, Ogarkov PI, Lebedev VF, Boiarintsev VV, Kuzin AA. Infektsionnye oslozhneniia politravm: mikrobiologicheskie i etiologicheskie aspekty. Vestn Khirurgiii im II Grekova. 2006;165(5):56-62. (in Russ.)
  48. Rozonova SM, Rudnov VA, Perevalova EYu, Shilova VP, Beikin YaB, Pionteck AE, Demetschenko VA, Bykov AS, Sorokino EE, Orlov AV, Drozd AV. Comparative analysis of etiology and antimicrobial resistance of the main nosocomial pathogens isolated from the ICUs in Ekaterinburg. KMAKh. 2005;7(4):410-18. (in Russ.)
  49. Duda AK. Antibiotikorezistentnost i puti ee preodoleniia. Training program for physicians Art of Treatment. 2017;(3):34-38. (in Russ.)
  50. Wright GD. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance. Trends Microbiol. 2016 Nov;24(11):862-71. doi: 10.1016/j.tim.2016.06.009
  51. Li J, Zhang H, Ning J, Sajid A, Cheng G, Yuan Z, Hao H. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control. 2019 Feb 22;8:44. doi: 10.1186/s13756-019-0489-3. eCollection 2019.
  52. Zeng L, Zhan Z, Hu L, Jiang X, Zhang Y, Feng J, Gao B, Zhao Y, Yang W, Yang H, Yin Z, Zhou D. Genetic Characterization of a bla VIM-24-Carrying IncP-7β Plasmid p1160-VIM and a bla VIM-4-Harboring Integrative and Conjugative Element Tn6413 From Clinical Pseudomonas aeruginosa. Front Microbiol. 2019 Feb 26;10:213. doi: 10.3389/fmicb.2019.00213. eCollection 2019.
  53. Pormohammad A, Pouriran R, Azimi H, Goudarzi M. Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis. IJBMS. 2019 Feb;22(2):118-27. doi: 10.22038/ijbms.2018.32052.7697
Address for correspondence:
21018, Ukraine,
Vinnitsa, Pirogov Str., 56,
National Pirogov Memorial Medical University,
Microbiology Department,
Tel. +38 097 729-37-61,
Oleksandr A. Nazarchuk
Information about the authors:
Nazarchuk Oleksandr A., PhD, Associate Professor of the Microbiology Department, National Pirogov Memorial Medical University, Vinnitsa, Ukraine.
Faustova Mariia O., PhD, Lecturer of the Department of Microbiology, Virology and Immunology, Ukrainian Medical Stomatological Academy, Poltava, Ukraine.
Kolodii Svetlana A., PhD, Associate Professor of the Microbiology Department, National Pirogov Memorial Medical University, Vinnitsa, Ukraine.
Contacts | ©Vitebsk State Medical University, 2007